Latest Industry Insights
Shark-Sourced Vaccine Ingredient May Be on Its Way Out
Shark-derived squalene is a common adjuvant product found in several approved vaccines. As calls for a sustainable source of squalene increase, researchers are exploring how yeast can be used to produce squalene analogues.
A Non-Invasive Treatment for Difficult-To-Treat Pediatric Brain Cancer
In this interview, Technology Networks spoke to Dr. Stuart Marcus, founder and chief medical officer of SonALAsense, to find out how ALA sonodynamic therapy could be a more effective treatment for diffuse intrinsic pontine glioma and recurrent glioblastoma.
What Do Advances in Structural Proteomics Mean for Drug Development?
This article will cover innovations in structural proteomics, a new way to identify drug targets across the proteome, a new method to dissect drug–protein interactions and the future of structure-based drug design.
A New Era of MS-Based Proteomics To Advance Human Wellness
Technology Networks spoke to Katherine Tran from SCIEX about the latest advances in data-independent acquisition mass spectrometry and how it can be used to further our understanding of the proteome in health and disease.
Connectivity, Flexibility and Integration in the Automated Lab
Through automating processes and workflows, scientists can optimize their time and concentrate on high-value tasks. At SLAS 2023, Technology Networks interviewed Lars Kristiansen, general manager of Agilent’s Automation Solutions Business. We discussed Agilent’s automation portfolio that was showcased at the event, in addition to trends and challenges in automation.
Automated Liquid Dispensing Supports Versatility in Biotech
Automated liquid handling methods are an attractive alternative to manual approaches, allowing labs to redirect important resources. At SLAS 2023, Technology Networks spoke with Thermo Fisher Scientific to discuss how automated liquid dispensing can support versatility in biotech.
Probing the Biomarker Landscape of Human Disease
To find out more about the importance of improving biomarker discovery and how next-generation mass spectrometry-based systems can help to fill the current gap in biomarker technologies, Technology Networks spoke with Dr. Mo Jain.
The UK Is Facing a Science and Tech Exodus
In this opinion piece, Liz Sparrow discusses the real risk of the UK losing its science and technology communities as they face a series of challenges that are threatening their growth.
Lipid Impurities in mRNA: Implications and Solutions
Dr. Adam Crowe sheds light on why a newly discovered reactive impurity is detrimental to mRNA function and how it can be detected more accurately.
Accelerating Efficient Drug Discovery With the Power of AI
To find out more about how generative artificial intelligence (AI) is helping to accelerate and advance drug discovery processes, we spoke to Dr. Alex Zhavoronkov, CEO of Insilico Medicine.